These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [The use of erythropoietin beta, two to three times per week, once per week and once every other week: meta-analysis of two clinical trials]. Pljesa S. Med Pregl; 2007; 60(3-4):123-7. PubMed ID: 17853722 [Abstract] [Full Text] [Related]
23. Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: systematic review and meta-analysis. Wilhelm-Leen ER, Winkelmayer WC. Am J Kidney Dis; 2015 Jul; 66(1):69-74. PubMed ID: 25636816 [Abstract] [Full Text] [Related]
24. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Aher SM, Ohlsson A. Cochrane Database Syst Rev; 2006 Jul 19; (3):CD004865. PubMed ID: 16856063 [Abstract] [Full Text] [Related]
27. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T. Ther Apher Dial; 2010 Jun 19; 14(3):240-75. PubMed ID: 20609178 [Abstract] [Full Text] [Related]
30. [Comparative study of the efficacy of different regimens of intermittent subcutaneous dosing of erythropoietin beta in treatment of renal anemia in chronic dialysis patients]. Nesić V, Ostrić V, Kovacević Z, Dimković N, Curić S, Lazarević M, Ratković M, Bogdanović J, Jelacić R. Med Pregl; 2005 Jun 19; 58(5-6):279-85. PubMed ID: 16526235 [Abstract] [Full Text] [Related]
31. HMG CoA reductase inhibitors (statins) for dialysis patients. Navaneethan SD, Shrivastava R. Cochrane Database Syst Rev; 2004 Oct 18; (4):CD004289. PubMed ID: 15495097 [Abstract] [Full Text] [Related]
34. Dosing patterns, drug costs, and hematologic outcome in anemic patients with chronic kidney disease switching from darbepoetin alfa to epoetin alfa. Hymes J, Bickimer T, Jackson JH, Bookhart BK, Mody SH, Tak Piech C. Curr Med Res Opin; 2007 Aug 18; 23(8):1931-7. PubMed ID: 17624232 [Abstract] [Full Text] [Related]
35. Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients. Ngo K, Kotecha D, Walters JA, Manzano L, Palazzuoli A, van Veldhuisen DJ, Flather M. Cochrane Database Syst Rev; 2010 Jan 20; (1):CD007613. PubMed ID: 20091643 [Abstract] [Full Text] [Related]
36. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis]. Martínez Castelao A, Reyes A, Valdés F, Otero A, López de Novales E, Pallardó L, Tabernero JM, Hernández Jaras J, Lladós F. Nefrologia; 2003 Jan 20; 23(2):114-24. PubMed ID: 12778875 [Abstract] [Full Text] [Related]
38. Hemoglobin targets for the anemia in patients with dialysis-dependent chronic kidney disease: a meta-analysis of randomized, controlled trials. Ye Y, Liu H, Chen Y, Zhang Y, Li S, Hu W, Yang R, Zhang Z, Lv L, Liu X. Ren Fail; 2018 Nov 20; 40(1):671-679. PubMed ID: 30741617 [Abstract] [Full Text] [Related]